Catalogo Articoli (Spogli Riviste)

HELP
ATTENZIONE: attualmente gli articoli Current Contents (fonte ISI) a partire dall'anno 2002 sono consultabili sulla Risorsa On-Line

Le informazioni sugli articoli di fonte ISI sono coperte da copyright

La ricerca find articoli where authors phrase all words ' Copolov, D' sort by level,fasc_key/DESCEND, pagina_ini_num/ASCEND ha restituito 58 riferimenti
Selezionare un intervallo

Per ulteriori informazioni selezionare i riferimenti di interesse.

    1. Lee, D; Wang, L; Dong, P; Tran, T; Copolov, D; Lim, AT
      Progesterone modulation of D5 receptor expression in hypothalamic ANP neurons, the role of estrogen

      MOLECULAR PSYCHIATRY
    2. Wood, SJ; Velakoulis, D; Smith, DJ; Bond, D; Stuart, GW; McGorry, PD; Brewer, WJ; Bridle, N; Eritaia, J; Desmond, P; Singh, B; Copolov, D; Pantelis, C
      A longitudinal study of hippocampal volume in first episode psychosis and chronic schizophrenia

      SCHIZOPHRENIA RESEARCH
    3. Dean, B; Sundram, S; Bradbury, R; Scarr, E; Copolov, D
      Studies on [H-3]CP-55940 binding in the human central nervous system: Regional specific changes in density of cannabinoid-1 receptors associated withschizophrenia and cannabis use

      NEUROSCIENCE
    4. Dean, B; Pavey, G; McLeod, M; Opeskin, K; Keks, N; Copolov, D
      A change in the density of [H-3]flumazenil, but not [H-3]muscimol binding,in Brodmann's Area 9 from subjects with bipolar disorder

      JOURNAL OF AFFECTIVE DISORDERS
    5. Velakoulis, D; Stuart, GW; Wood, SJ; Smith, DJ; Brewer, WJ; Desmond, P; Singh, B; Copolov, D; Pantelis, C
      Selective bilateral hippocampal volume loss in chronic schizophrenia

      BIOLOGICAL PSYCHIATRY
    6. Bell, R; McLaren, A; Copolov, D
      How reliable are reported plasma clozapine levels?

      AUSTRALIAN AND NEW ZEALAND JOURNAL OF PSYCHIATRY
    7. Silberstein, RB; Line, P; Pipingas, A; Copolov, D; Harris, P
      Steady-state visually evoked potential topography during the continuous performance task in normal controls and schizophrenia

      CLINICAL NEUROPHYSIOLOGY
    8. Lee, D; Huang, W; Wang, L; Copolov, D; Lim, AT
      Glucocorticoid modulation of dopamine mediated effects on hypothalamic atrial natriuretic factor neurons

      MOLECULAR PSYCHIATRY
    9. Pralong, D; Tomaskovic-Crook, E; Opeskin, K; Copolov, D; Dean, B
      Serotonin(2A) receptors are reduced in the planum temporale from subjects with schizophrenia

      SCHIZOPHRENIA RESEARCH
    10. Mallard, C; Loeliger, M; Copolov, D; Rees, S
      Reduced number of neurons in the hippocampus and the cerebellum in the postnatal guinea-pig following intrauterine growth-restriction

      NEUROSCIENCE
    11. Copolov, D; Velakoulis, D; McGorry, P; Mallard, C; Yung, A; Rees, S; Jackson, G; Rehn, A; Brewer, W; Pantelis, C
      Neurobiological findings in early phase schizophrenia

      BRAIN RESEARCH REVIEWS
    12. Copolov, D; Crook, J
      Biological markers and schizophrenia

      AUSTRALIAN AND NEW ZEALAND JOURNAL OF PSYCHIATRY
    13. Velakoulis, D; McGorry, P; Copolov, D; Pantelis, C
      Hippocampal and superior temporal gyrus volume in first-episode schizophrenia - In reply

      ARCHIVES OF GENERAL PSYCHIATRY
    14. Copolov, D
      Menders of the mind: A history of the Royal Australian and New Zealand College of Psychiatrists, 1946-1996

      AMERICAN JOURNAL OF PSYCHIATRY
    15. Mallard, EC; Rehn, A; Rees, S; Tolcos, M; Copolov, D
      Ventriculomegaly and reduced hippocampal volume following intrauterine growth-restriction: implications for the aetiology of schizophrenia

      SCHIZOPHRENIA RESEARCH
    16. Torrey, F; Jablensky, A; Pearlson, G; Knable, M; Adityanjee; Ingraham, L; Africa, B; De Lisi, L; Wildenauer, D; Copolov, D; Buka, S; Murray, R; Stevens, J; Jones, P; Rund, B; Goldberg, T; Gallhofer, B; Falkai, P; Tsuang, M; Schroder, J; Bogerts, B; Friedman, L; Bogerts, B; Lawson, B; Bachus, S; Post, R; Haas, G
      Stanley Foundation Satellite Symposium, Santa Fe, New Mexico, Saturday, April 17, 1999

      SCHIZOPHRENIA RESEARCH
    17. Lee, D; Dong, P; Copolov, D; Lim, AT
      D-5 dopamine receptors mediate estrogen-induced stimulation of hypothalamic atrial natriuretic factor neurons

      MOLECULAR ENDOCRINOLOGY
    18. Dean, B; Scarr, E; Bradbury, R; Copolov, D
      Decreased hippocampal (CA3) NMDA receptors in schizophrenia

      SYNAPSE
    19. Dean, B; Tomaskovic-Crook, E; Opeskin, K; Keks, N; Copolov, D
      No change in the density of the serotonin(1A) receptor, the serotonin(4) receptor or the serotonin transporter in the dorsolateral prefrontal cortex from subjects with schizophrenia

      NEUROCHEMISTRY INTERNATIONAL
    20. O'Neill, M; Brewer, W; Thornley, C; Copolov, D; Warne, G; Sinclair, A; Forrest, S; Williamson, R
      Kallmann syndrome gene (KAL-X) is not mutated in schizophrenia

      AMERICAN JOURNAL OF MEDICAL GENETICS
    21. Crook, JM; Dean, B; Pavey, G; Copolov, D
      The binding of [H-3]AF-DX 384 is reduced in the Caudate-Putamen of subjects with schizophrenia

      LIFE SCIENCES
    22. Copolov, D
      Hubris and humility in the life of the schizophrenia researcher

      AUSTRALIAN AND NEW ZEALAND JOURNAL OF PSYCHIATRY
    23. Velakoulis, D; Pantelis, C; McGorry, PD; Dudgeon, P; Brewer, W; Cook, M; Desmond, P; Bridle, N; Tierney, P; Murrie, V; Singh, B; Copolov, D
      Hippocampal volume in first-episode psychoses and chronic schizophrenia - A high-resolution magnetic resonance imaging study

      ARCHIVES OF GENERAL PSYCHIATRY
    24. NAYLOR L; DEAN B; PEREIRA A; MACKINNON A; KOUZMENKO A; COPOLOV D
      NO ASSOCIATION BETWEEN THE SEROTONIN TRANSPORTER-LINKED PROMOTER REGION POLYMORPHISM AND EITHER SCHIZOPHRENIA OR DENSITY OF THE SEROTONIN TRANSPORTER IN HUMAN HIPPOCAMPUS

      Molecular medicine (Cambridge, Mass.)
    25. Dean, B; Hayes, W; Hill, C; Copolov, D
      Decreased Serotonin(2A) receptors in Brodmann's area 9 from schizophrenic subjects - A pathological or pharmacological phenomenon?

      MOLECULAR AND CHEMICAL NEUROPATHOLOGY
    26. BREWER W; FRANCEY S; YUNG A; VELAKOULIS D; ANDERSON V; MCGORRY P; SINGH B; COPOLOV D; PANTELIS C
      COGNITIVE AND OLFACTORY DEFICITS - COURSE FROM HIGH-RISK TO FIRST-EPISODE PSYCHOSIS

      Schizophrenia research
    27. BREWER W; VELAKOULIS D; ANDERSON V; LAMBERT J; MCGORRY P; SINGH B; COPOLOV D; PANTELIS C
      OLFACTORY ACUITY DEFICITS FOR THE ODOR OF SCHIZOPHRENIA IN CHRONIC AND FIRST-EPISODE PATIENTS

      Schizophrenia research
    28. VELAKOULIS D; PANTELIS C; MCGORRY P; YUNG A; BREWER WJ; BRIDLE N; TIERNEY P; LE T; DESMOND PM; SINGH B; COPOLOV D
      CAUDATE VOLUME CHANGES ACROSS 3 STAGES OF PSYCHOSIS

      Schizophrenia research
    29. VELAKOULIS D; PANTELIS C; STUART G; MCGORRY P; YUNG A; BREWER WJ; BRIDLE N; DESMOND PM; SINGH B; COPOLOV D
      THE SITE OF HIPPOCAMPAL VOLUME REDUCTION DIFFERS BETWEEN FIRST-EPISODE AND CHRONIC-SCHIZOPHRENIA

      Schizophrenia research
    30. FARNBACHPRALONG D; BRADBURY R; COPOLOV D; DEAN B
      CLOZAPINE AND OLANZAPINE TREATMENT DECREASES RAT CORTICAL AND LIMBIC GABA(A) RECEPTORS

      European journal of pharmacology
    31. BELL R; MCLAREN A; GALANOS J; COPOLOV D
      THE CLINICAL USE OF PLASMA CLOZAPINE LEVELS

      Australian and New Zealand Journal of Psychiatry
    32. CROOK JM; TOMASKOVIC EM; DEAN B; COPOLOV D
      A POSSIBLE MUSCARINIC INVOLVEMENT IN SCHIZOPHRENIA - REDUCED M(1) RECEPTOR MEASUREMENT IN HUMAN HIPPOCAMPUS

      Schizophrenia research
    33. COPOLOV D; CROOK J; OPESKIN K; HILL C; KEKS N; DEAN B
      MUSCARINIC M(1) RECEPTORS IN THE CAUDATE-PUTAMEN OF PATIENTS WITH SCHIZOPHRENIA - DECREASED RECEPTOR DENSITY IS NOT ACCOMPANIED BY DECREASED RECEPTOR MESSENGER-RNA

      Schizophrenia research
    34. KEKS NA; HILL C; ROBERTS S; DEAN B; OPESKIN K; MACKINNON A; COPOLOV D
      DIAGNOSTIC INSTRUMENT FOR BRAIN STUDIES (DIBS)

      Schizophrenia research
    35. COPOLOV D; HEADLAM D; MACKINNON A; MCKAY C; THOMAS R
      RECENT HALLUCINATORS DEMONSTRATE ABNORMALITIES OF CENTRAL AUDITORY PROCESSING

      Schizophrenia research
    36. MARZELLA PL; COPOLOV D
      [H-3] NEMONAPRIDE BINDING IN HUMAN CAUDATE AND PUTAMEN

      Brain research bulletin
    37. CROOK JM; TOMASKOVIC E; PAVEY G; DEAN B; COPOLOV D
      METHODOLOGICAL CONSIDERATIONS FOR M-1 RECEPTOR ANALYSIS AND THE SUBSEQUENT MEASUREMENT OF REDUCED M-1 RECEPTOR DENSITY IN SCHIZOPHRENIA

      Journal of neurochemistry
    38. MARZELLA PL; HILL C; KEKS N; SINGH R; COPOLOV D
      THE BINDING OF BOTH [H-3] NEMONAPRIDE AND [H-3] RACLOPRIDE IS INCREASED IN SCHIZOPHRENIA

      Biological psychiatry
    39. SMITH D; PANTELIS C; MCGRATH J; TANGAS C; COPOLOV D
      OCULAR ABNORMALITIES IN CHRONIC-SCHIZOPHRENIA - CLINICAL IMPLICATIONS

      Australian and New Zealand Journal of Psychiatry
    40. COPOLOV D
      NEW NAME FOR ATYPICAL ANTIPSYCHOTICS

      The American journal of psychiatry
    41. COPOLOV D
      DIAGNOSIS AND PHENOMENOLOGY OF SCHIZOPHRENIA AND RELATED DISORDERS

      Current opinion in psychiatry
    42. OPESKIN K; DEAN B; PAVEY G; HILL C; KEKS N; COPOLOV D
      NEITHER PROTEIN-KINASE-C NOR ADENYLATE-CYCLASE ARE ALTERED IN THE STRIATUM FROM SUBJECTS WITH SCHIZOPHRENIA

      Schizophrenia research
    43. KULKARNI J; DECASTELLA A; SMITH D; TAFFE J; KEKS N; COPOLOV D
      A CLINICAL-TRIAL OF THE EFFECTS OF ESTROGEN IN ACUTELY PSYCHOTIC WOMEN

      Schizophrenia research
    44. BREWER WJ; SMITH DJ; VELAKOULIS D; ANDERSON V; MCGORRY P; COPOLOV D; SINGH B; PANTELIS C
      OLFACTORY AND NEUROPSYCHOLOGICAL DEFICITS IN FIRST EPISODE PSYCHOSIS

      Schizophrenia research
    45. ROBERTS S; HILL C; DEAN B; KEKS N; OPESKIN K; COPOLOV D
      THE POSTMORTEM DIAGNOSIS OF SCHIZOPHRENIA - SOME PSYCHOSOCIAL AND CLINICAL IMPLICATIONS

      Schizophrenia research
    46. VELAKOULIS D; PANTELIS C; COOK MJ; MURRIE V; DESMOND PM; TRESS BM; BREWER WJ; SINGH B; COPOLOV D
      BILATERAL HIPPOCAMPAL VOLUME REDUCTION IN CHRONIC-SCHIZOPHRENIA ON MRI VOLUMETRIC-ANALYSIS

      Schizophrenia research
    47. NAYLOR L; DEAN B; OPESKIN K; PAVEY G; HILL C; KEKS N; COPOLOV D
      CHANGES IN THE SEROTONIN TRANSPORTER IN THE HIPPOCAMPUS OF SUBJECTS WITH SCHIZOPHRENIA IDENTIFIED USING [H-3] PAROXETINE

      Journal of neural transmission
    48. HILL C; KEKS N; ROBERTS S; OPESKIN K; DEAN B; MACKINNON A; COPOLOV D
      PROBLEM OF DIAGNOSIS IN POSTMORTEM BRAIN STUDIES OF SCHIZOPHRENIA

      The American journal of psychiatry
    49. COPOLOV D; CARTER D
      THE MENTAL-HEALTH-RESEARCH-INSTITUTE UNUSUAL PERCEPTIONS SCHEDULE (MUPS)

      Schizophrenia research
    50. DEAN B; OPESKIN K; NAYLOR L; PAVEY G; HILL C; COPOLOV D; KEKS N
      ALTERED HIPPOCAMPAL [H-3] PAROXETINE BINDING IN SUBJECTS WITH SCHIZOPHRENIA

      Schizophrenia research
    51. COPOLOV D; LEE D; HUANG W; LIM A
      D2 RECEPTOR-MEDIATED SUPPRESSION OF IRANF SECRETION FROM HYPOTHALAMICNEURONS DOES NOT INVOLVE TYPE-II ADENYLYL CYCLASES

      Schizophrenia research
    52. LAMBERT T; KEKS N; MCGRATH J; CATTS S; HUSTIG H; VADDADI K; BURROWS G; VARGHESE F; GEORGE T; KERR K; JOHNSON G; BURNETT P; ZORBAS A; HILL C; COPOLOV D
      REMOXIPRIDE VERSUS THIORIDAZINE IN THE TREATMENT OF FIRST EPISODES OFSCHIZOPHRENIA IN DRUG-NAIVE PATIENTS - A CASE FOR SPECIFIC, LOW POTENCY D-2 ANTAGONISTS

      Human psychopharmacology
    53. WONG MTH; BREWER W; CARTER D; COPOLOV D
      EPILEPSY AS A DIFFERENTIAL-DIAGNOSIS FOR MULTIMODAL HALLUCINATIONS - A CASE-REPORT

      Epilepsia
    54. SUNDRAM S; DEAN B; COPOLOV D
      DOPAMINE UPTAKE IN PLATELETS - RESPONSE

      Biological psychiatry
    55. KULKARNI J; DECASTELLA A; SMITH D; MCKENZIE D; KEKS N; SINGH B; COPOLOV D
      GONADOTROPIN-RESPONSE TO NALOXONE CHALLENGE IN FEMALE AND MALE PSYCHOTIC-PATIENTS - A PILOT-STUDY

      Biological psychiatry
    56. KULKARNI J; SMITH D; MCKENZIE D; HILL C; KEKS N; SINGH B; COPOLOV D
      GONADOTROPIN-RESPONSE TO NALOXONE CHALLENGE IN MALE AND FEMALE PSYCHOTIC-PATIENTS

      Schizophrenia research
    57. MCGORRY PD; MIHALOPOULOS C; HARRIGAN S; MCKENZIE D; HENRY L; DAKIS J; JACKSON H; KULKARNI J; COPOLOV D
      SPURIOUS PRECISION - VARIABILITY IN PROCEDURAL VALIDITY OF DIAGNOSTICMETHODS IN PSYCHOTIC DISORDERS AND IMPLICATIONS FOR RESEARCH AND TREATMENT

      Schizophrenia research
    58. KEKS N; MCGRATH J; LAMBERT T; CATTS S; VADDADI K; BURROWS G; VARGHESE F; GEORGE T; HUSTIG H; BURNETT P; KERR K; ZORBAS A; HILL C; STEDMAN T; JOHNSON G; LEIBERT B; COPOLOV D; MACKENZIE M; DILLENBECK C
      THE AUSTRALIAN MULTICENTER DOUBLE-BLIND COMPARATIVE-STUDY OF REMOXIPRIDE AND THIORIDAZINE IN SCHIZOPHRENIA

      Acta psychiatrica Scandinavica


ASDD Area Sistemi Dipartimentali e Documentali, Università di Bologna, Catalogo delle riviste ed altri periodici
Documento generato il 24/10/20 alle ore 14:48:08